Key result
Stroke-related mortality in Alzheimer's disease dropped ~46% in the US from 1999 to 2023.
Observational (n=154,323)
Yes
Answers are grounded in this paper and cite their sources.
Stroke-related mortality in Alzheimer's disease patients has significantly declined over the past 25 years, though disparities persist among women, non-Hispanic Blacks, and rural populations.
Introduction: Alzheimer’s Disease (AD) and stroke, both age-related conditions, share common risk factors including hypertension, smoking, diabetes, and the APOE E4 genotype, frequently coexisting in older adults. Research Question: How have stroke-related mortality patterns among AD patients changed in the U.S. from 1999 to 2023? Objectives: To examine disparities in stroke-related mortality among AD patients by sex, race/ethnicity, and geographic region. Methods: Age-adjusted mortality rates (AAMRs) per 100,000 in adults (65+) were obtained from CDC WONDER using ICD codes for AD (G30) and stroke (I60–I61, I63–I64, I69). Joinpoint regression estimated Annual Percent Change (APC) and Average APC (AAPC), with significance at p<0.01. Results: From 1999 to 2023, 154,323 stroke-related deaths occurred in AD patients, primarily in nursing homes (53.4%) and private residences (20%). The AAMR declined from 19.4 in 1999 to 10.5 in 2023 (AAPC: -2.6%, 95% CI: -3.0 to -2.3, p<0.000001). Women had higher AAMRs than men (15.9 vs. 12.6), though men saw a steeper decline (AAPC: -2.7%, 95% CI: -3.2 to -2.3, p<0.000001). Non-Hispanic (NH) Blacks had the highest AAMR (16.9), while NH Whites showed the greatest decline (AAPC: -2.7%, 95% CI: -3.2 to -2.3, p<0.000001). AAMRs ranged from 27 in Mississippi to 6 in New York, with the Northeast showing the largest decline (AAPC: -3.5%, 95% CI: -3.9 to -3.0, p<0.000001). Rural areas had higher AAMRs than urban (19.4 vs. 14.3), with both experiencing declining trends. Conclusion: Stroke-related mortality in AD patients has declined but remains unevenly distributed, with disparities among women, NH Blacks, rural communities and those from the West. Targeted interventions are needed.
No takes yet. Share an insight, caveat, or question.
Malik et al. (2025) conducted an observational in Alzheimer's Disease and stroke (n=154,323). Time period (1999-2023) vs. 1999 was evaluated on Age-adjusted mortality rate (AAMR) per 100,000 (AAPC -2.6%, 95% CI -3.0 to -2.3, p=<0.000001). From 1999 to 2023, the age-adjusted stroke-related mortality rate among U.S. adults with Alzheimer's Disease declined from 19.4 to 10.5 per 100,000.
Synapse has enriched 10 related papers. Consider them for comparative context: